학술논문
BAFF and APRIL as osteoclast-derived survival factors for myeloma cells: a rationale for TACI-Fc treatment in patients with multiple myeloma.
Document Type
Letter
Source
Subject
*LETTERS to the editor
*LEUKEMIA
*
Language
ISSN
0887-6924
Abstract
A letter to the editor is presented in response to the article "BAFF and APRIL as osteoclast-derived survival factors for myeloma cells: a rationale for TACI-Fc treatment in patients with multiple myeloma" that appeared online in the April 13, 2006 issue of "Leukemia."